<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Biochim Biophys Acta</journal-id>
      <journal-title-group>
        <journal-title>Biochimica et Biophysica Acta</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0006-3002</issn>
      <publisher>
        <publisher-name>Elsevier Pub. Co</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3092864</article-id>
      <article-id pub-id-type="pmid">21376144</article-id>
      <article-id pub-id-type="publisher-id">BBAPAP38592</article-id>
      <article-id pub-id-type="doi">10.1016/j.bbapap.2011.02.008</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The neurotransmitter serotonin interrupts α-synuclein amyloid maturation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Falsone</surname>
            <given-names>S. Fabio</given-names>
          </name>
          <email>fabio.falsone@uni-graz.at</email>
          <xref rid="af0005" ref-type="aff">a</xref>
          <xref rid="cr0005" ref-type="corresp">⁎</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leitinger</surname>
            <given-names>Gerd</given-names>
          </name>
          <xref rid="af0010" ref-type="aff">b</xref>
          <xref rid="af0015" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Karner</surname>
            <given-names>Anita</given-names>
          </name>
          <xref rid="af0020" ref-type="aff">d</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kungl</surname>
            <given-names>Andreas J.</given-names>
          </name>
          <xref rid="af0020" ref-type="aff">d</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kosol</surname>
            <given-names>Simone</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cappai</surname>
            <given-names>Roberto</given-names>
          </name>
          <xref rid="af0025" ref-type="aff">e</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zangger</surname>
            <given-names>Klaus</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
        </contrib>
      </contrib-group>
      <aff id="af0005"><label>a</label>Institute of Chemistry, University of Graz, Heinrichstrasse 28, A-8010 Graz, Austria</aff>
      <aff id="af0010"><label>b</label>Institute of Cell Biology, Histology and Embryology, Center of Molecular Medicine, Medical University of Graz, 8010 Graz, Austria</aff>
      <aff id="af0015"><label>c</label>Center for Medical Research, Core Facility Ultrastructure Analysis, Medical University of Graz, 8010 Graz, Austria</aff>
      <aff id="af0020"><label>d</label>Institute of Pharmaceutical Sciences, University of Graz, A-8010 Graz, Austria</aff>
      <aff id="af0025"><label>e</label>Department of Pathology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Victoria 3010, Australia</aff>
      <author-notes>
        <corresp id="cr0005"><label>⁎</label>Corresponding author. Tel.: +43 316 3805326; fax: +43 316 3809840. <email>fabio.falsone@uni-graz.at</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <volume>1814</volume>
      <issue>5</issue>
      <fpage>553</fpage>
      <lpage>561</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>7</month>
          <year>2010</year>
        </date>
        <date date-type="rev-recd">
          <day>10</day>
          <month>2</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>2</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2011 Elsevier B.V.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>Elsevier B.V.</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Indolic derivatives can affect fibril growth of amyloid forming proteins. The neurotransmitter serotonin (5-HT) is of particular interest, as it is an endogenous molecule with a possible link to neuropsychiatric symptoms of Parkinson disease. A key pathomolecular mechanism of Parkinson disease is the misfolding and aggregation of the intrinsically unstructured protein α-synuclein. We performed a biophysical study to investigate an influence between these two molecules. In an isolated in vitro system, 5-HT interfered with α-synuclein amyloid fiber maturation, resulting in the formation of partially structured, SDS-resistant intermediate aggregates. The C-terminal region of α-synuclein was essential for this interaction, which was driven mainly by electrostatic forces. 5-HT did not bind directly to monomeric α-synuclein molecules and we propose a model where 5-HT interacts with early intermediates of α-synuclein amyloidogenesis, which disfavors their further conversion into amyloid fibrils.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <title>Research highlights</title>
        <p>► The neurotransmitter serotonin (5-HT) suppresses amyloid fibril growth of alpha-synuclein (AS). ► 5-HT binds to intermediate aggregates of alpha-synuclein, not to monomeric AS. Consequently, 5-HT does not influence initial steps of amyloidogenesis. ► 5-HT promotes the accumulation of partially structured, SDS-resistant “on pathway” aggregates of AS. ► The C-terminal region of AS is essential for a charge dependent interaction. ► “On pathway” and “off-pathway” aggregations of AS might mechanistically overlap.</p>
      </abstract>
      <kwd-group>
        <title>Abbreviations</title>
        <kwd>AS, α-synuclein</kwd>
        <kwd>5-HT, serotonin</kwd>
        <kwd>5,7-HT, 5,7 dihydroxytryptamine</kwd>
        <kwd>5-HIAA, 5-hydroxyindoleacetic acid</kwd>
        <kwd>ThioT, thioflavin T</kwd>
        <kwd>TEM, transmission electron spectroscopy</kwd>
        <kwd>DLS, dynamic light scattering</kwd>
        <kwd>NAC-region, non-Aβ component region</kwd>
      </kwd-group>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Protein misfolding</kwd>
        <kwd>Amyloid</kwd>
        <kwd>Aggregation</kwd>
        <kwd>Parkinson disease</kwd>
        <kwd>Neurodegeneration</kwd>
        <kwd>Indoleamine</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s0005">
      <label>1</label>
      <title>Introduction</title>
      <p>The 14 kDa polypeptide α-synuclein (AS) is a signature protein of Parkinson disease (PD), a neuromotor disorder which is characterized by the death of dopaminergic neurons within the substantia nigra of the brain <xref rid="bb0005" ref-type="bibr">[1]</xref>. AS is the major constituent of proteinaceous amyloidogenic inclusions known as Lewy bodies, which are the histological hallmarks of PD <xref rid="bb0010 bb0015 bb0020" ref-type="bibr">[2–4]</xref>.</p>
      <p>AS is intrinsically unstructured <xref rid="bb0025" ref-type="bibr">[5]</xref>. It is composed of an N-terminal amphipathic region, a central aggregation prone NAC (non-Aβ-component) hydrophobic region, and an acidic C-terminal region. The high degree of conformational freedom within these regions influences folding and aggregation of AS, two processes that closely couple this molecule to neurotoxicity <xref rid="bb0030" ref-type="bibr">[6]</xref>. While AS adopts β-sheet conformation in amyloid fibrils <xref rid="bb0035" ref-type="bibr">[7]</xref>, soluble folding intermediates assemble into aggregates of different size and shape <xref rid="bb0040 bb0045 bb0050 bb0055 bb0060 bb0065 bb0070" ref-type="bibr">[8–14]</xref>. A growing number of studies suggest that the neurotoxic agents of the disease are soluble, intermediately folded AS-oligomers rather than amyloid fibrils <xref rid="bb0040 bb0045 bb0050 bb0055 bb0060 bb0065 bb0075" ref-type="bibr">[8–13,15]</xref>. The generation of soluble aggregates depends on a number of factors such as natural mutations of the AS gene, molecular chaperones, and the interaction with several chemically and functionally unrelated small molecule ligands <xref rid="bb0030" ref-type="bibr">[6]</xref>. The non-homogeneous nature of these folding intermediates is reflected in their variable cytotoxic activity. Some conditions force the accumulation of non-toxic aggregates <xref rid="bb0080 bb0085" ref-type="bibr">[16,17]</xref>, while others promote pronouncedly neurotoxic species <xref rid="bb0045 bb0060 bb0065" ref-type="bibr">[9,12,13]</xref>.</p>
      <p>Several studies suggest that, in PD, the crucial interplay between AS and the neurotransmitter dopamine, dopamine oxidation intermediates, and other catechols promotes the generation of distinct aggregates and they may represent toxic species triggering dopaminergic cell death <xref rid="bb0090 bb0095 bb0100 bb0105 bb0110 bb0115 bb0120 bb0125" ref-type="bibr">[18–25]</xref> and ultimately neuromotoric impairment. Intriguingly, it was suggested that an indolic oxidation intermediate of dopamine, namely 5,6-dihydroxylindole, interferes with the assembly of AS rather than dopamine itself <xref rid="bb0130 bb0135" ref-type="bibr">[26,27]</xref>. Indole-scaffold derivatives affecting the assembly of different amyloid forming proteins have also been identified in various small molecule screening assays <xref rid="bb0140 bb0145 bb0150 bb0155 bb0160" ref-type="bibr">[28–32]</xref>. The indoleamine neurotransmitter serotonin (5-HT) <xref rid="bb0145" ref-type="bibr">[29]</xref> captured our particular attention, since in neurodegenerative diseases, altered levels of 5-HT are linked to neuropsychiatric impairments such as sleep abnormalities, depression, and anxiety <xref rid="bb0165 bb0170 bb0175 bb0180" ref-type="bibr">[33–36]</xref>. In PD, altered 5-HT metabolism may be linked to the non-motor symptoms of the disease <xref rid="bb0175" ref-type="bibr">[35]</xref>. This led us to investigate whether 5-HT affects the folding and aggregation of AS, in analogous manner to what has been established for dopamine and its derivatives.</p>
      <p>We found that, in an in vitro isolated system, 5-HT binds to and stabilizes AS aggregates of a heterogeneous composition, which consequently accumulate instead of growing into mature fibrils. This effect is particularly sensitive to charge perturbations, and we identify a prevalent role for electrostatic interaction with the C-terminal region of AS.</p>
    </sec>
    <sec sec-type="materials|methods" id="s0010">
      <label>2</label>
      <title>Materials and methods</title>
      <p>Unless specified otherwise, all reagents were from Sigma (St. Louis, MO).</p>
      <sec id="s0015">
        <label>2.1</label>
        <title>Protein expression and purification</title>
        <p>The pRSETB vectors containing the human <italic>AS</italic> gene and the <italic>ASΔ96</italic> gene were transformed into BL21 (DE3) Star cells (Invitrogen, Carlsbad, CA). AS was expressed in LB medium containing 100 μg/ml ampicillin. <sup><sup>15</sup></sup>N-labeled AS (<sup><sup>15</sup></sup>N-AS) was expressed in minimal medium (6.8 g/l Na<sub>2</sub>HPO<sub>4</sub>, 3 g/l KH<sub>2</sub>PO<sub>4</sub>, 0.5 g/l NaCl, 1.5 g/l (<sup><sup>15</sup></sup>NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 2 g/l glucose, 1 μg/l biotin, 1 μg/l thiamin, 100 μg/ml ampicillin, and 1 ml 1000× microsalts).</p>
        <p>Cultures were grown at 37 °C to an OD<sub>600</sub> of 0.7. The protein expression was induced by the addition of 1 mM IPTG. After 4 h, cells were harvested by centrifugation at 6000<italic>g</italic> for 15 min at 4 °C. The cells were resuspended in 20 mM Tris–HCl, 50 mM NaCl, pH 7.4 (buffer A), supplemented with a Complete<sup>®</sup> protease inhibitor mix (Roche, Basel, Switzerland) and disrupted on ice by sonification. After centrifugation, an acid precipitation step was performed by lowering the pH to 4 and stirring for 20 min at 4 °C. The precipitate was removed by centrifugation at 20,000<italic>g</italic> for 1 h and the supernatant was loaded onto a Source Q column which was previously equilibrated with buffer A. The elution was carried out using a gradient from 50 mM to 600 mM NaCl. The fractions containing protein were pooled, loaded on a Superdex 75 gel filtration column (GE Healthcare, Uppsala, Sweden), and eluted with H<sub>2</sub>O. The purified protein was aliquoted, lyophilized, and stored at − 80 °C.</p>
        <p>ASΔ96 was expressed in LB-medium containing 100 μg/ml ampicillin. The purification was similar to that of AS, except that a heat precipitation step was performed instead of acid precipitation (80 °C, 10 min under stirring). Also, an SP-sepharose column (GE Healthcare, Uppsala, Sweden) was used instead of a Source Q column.</p>
      </sec>
      <sec id="s0020">
        <label>2.2</label>
        <title>Thioflavin T (ThioT) and turbidity measurements</title>
        <p>Unless otherwise described, a 100 μM AS or ASΔ96 solution in 20 mM Tris–HCl, 150 mM NaCl, 3 mM NaN<sub>3</sub>, pH 7.4, was agitated in a thermomixer (Eppendorf, Hamburg, Germany) at 37 °C and 1200 rpm. Ten microliter aliquots were taken at the indicated time points and diluted into a five micromolar ThioT solution prepared in the same buffer. Spectra of the samples were recorded on a Cary Eclipse fluorescence spectrometer (Varian, Palo Alto, CA) at 25 °C and 482 nm upon excitation at 442 nm. The slit widths were set to 10 nm and 20 nm for excitation and emission, respectively.</p>
        <p>The turbidity of the same samples was measured on a Cary Eclipse fluorescence spectrometer (Varian, Palo Alto, CA) at 25 °C with excitation and emission wavelengths set at 360 nm using a slit width of 5 nm for both excitation and emission.</p>
        <p>The values are averages including S.E. of three independent determinations.</p>
      </sec>
      <sec id="s0025">
        <label>2.3</label>
        <title>Circular dichroism</title>
        <p>Far-UV-circular dichroism measurements were performed at 25 °C on a J-715 spectropolarimeter (Jasco, Tokyo, Japan) with a response time of 2 s and with a data point resolution of 0.1 nm using a 0.1 cm quartz cuvette. The spectra were recorded by diluting the samples in 20 mM NaPi, pH 7.4. Three scans were averaged to obtain smooth spectra.</p>
        <p>To eliminate the signal contribution of residual monomeric AS from the aggregate spectrum, the ratio of monomer to oligomer AS was determined by 1H-NMR under the assumption that no other species is present in solution. This was then subtracted from the original spectrum.</p>
        <p>Mean residue ellipticity calculations and secondary structure deconvolution analysis were performed on the DICHROWEB platform <xref rid="bb0185" ref-type="bibr">[37]</xref> by applying the SELCON3 algorithm <xref rid="bb0190" ref-type="bibr">[38]</xref>.</p>
      </sec>
      <sec id="s0030">
        <label>2.4</label>
        <title>Dynamic light scattering (DLS)</title>
        <p>Stokes radii were determined using a DynaPro instrument (Protein Solutions, Lakewood, NJ) in a 1.5 mm pathlength 12 μl quartz cuvette at 25 °C. Samples were centrifuged before measuring. The values are averages including S.E. of three independent determinations.</p>
      </sec>
      <sec id="s0035">
        <label>2.5</label>
        <title>NMR spectroscopy</title>
        <p>All NMR spectra were acquired at 300 K on a Bruker Avance DRX 500 MHz NMR spectrometer equipped with a 5 mm TXI triple-resonance probe and <italic>z</italic>-axis gradients. One-dimensional <sup><sup>1</sup></sup>H-NMR spectra were recorded on a solution containing 50 μM 5-HT and 100 μM AS in 20 mM Tris–d<sub>11</sub>, 150 mM NaCl, 3 mM NaN<sub>3</sub>, pH 7.4, and containing 10% (vol./vol.) of D<sub>2</sub>O. The solution was shaken for 7 days at 1200 rpm at 37 °C. Every 24 h, a one-dimensional <sup><sup>1</sup></sup>H NMR spectrum with Watergate solvent suppression was acquired with 1024 scans. Two-dimensional <sup><sup>1</sup></sup>H-<sup><sup>15</sup></sup>N-HSQC spectra were recorded on a 100 μM AS solution in 50 mM NaPi, 50 mM NaCl, 3 mM NaN<sub>3</sub>, pH 6.5, in the absence and in the presence of 1 mM 5-HT. Ten percent D<sub>2</sub>O were added for field-frequency locking. Data were processed using NMRPipe <xref rid="bb0195" ref-type="bibr">[39]</xref>.</p>
      </sec>
      <sec id="s0040">
        <label>2.6</label>
        <title>Transmission electron spectroscopy</title>
        <p>A protein suspension was placed onto carbon-coated grids, blot dried, and rinsed in distilled water for 1 min. Negative staining was performed by applying 1% uranyl acetate for 1 min and blotting the liquid with filter paper. Afterwards, the samples were air-dried and viewed with a Zeiss EM 901 transmission electron microscope.</p>
      </sec>
      <sec id="s0045">
        <label>2.7</label>
        <title>Ultrafiltration assays</title>
        <p>A 100 μM AS solution in 20 mM Tris–HCl, 150 mM NaCl, pH 7.4, was agitated in a thermomixer (Eppendorf, Hamburg, Germany) at 37 °C and 1200 rpm in the presence of equimolar amounts of 5-HT. Fifty microliters of the solution were then removed at given times and spun at 13,000<italic>g</italic> for 5 min through an Amicon Ultra-0.5 centrifugal filter device (Millipore, Billerica, MA) with a membrane cutoff of 3 kDa. The amount of 5-HT recovered in the flow-through was detected by fluorescence emission spectroscopy after excitation of 295 nm. Emission spectra were recorded between 300 and 400 nm on a Cary Eclipse fluorescence spectrometer.</p>
      </sec>
      <sec id="s0050">
        <label>2.8</label>
        <title>Denaturing SDS–PAGE</title>
        <p>A 100 μM AS solution in 20 mM Tris–HCl, 150 mM NaCl, 3 mM NaN<sub>3</sub>, pH 7.4, was agitated at 37 °C and 1200 rpm in the absence and presence of 1 mM 5-HT. Two microliter aliquots were collected at given times and resolved on a 4%–12% SDS–PAGE gel. Proteins were visualized by silver staining.</p>
      </sec>
    </sec>
    <sec id="s0055">
      <label>3</label>
      <title>Results</title>
      <sec id="s0060">
        <label>3.1</label>
        <title>5-HT promotes the accumulation of partially structured aggregates</title>
        <p>We first tested whether 5-HT was able to influence the growth of AS amyloid fibrils by agitating an AS sample at 37 °C over several days. Fibril growth was monitored by the dye Thioflavin T (ThioT), which exhibits a fluorescence emission maximum at 482 nm when bound to mature fibrils but not to monomeric or pre-fibrillar species <xref rid="bb0200" ref-type="bibr">[40]</xref>. ThioT fluorescence increased in the absence of 5-HT indicated that fibril growth proceeded following an initial lag phase, reaching a plateau around 80 h (<xref rid="f0005" ref-type="fig">Fig. 1</xref>A). ThioT fluorescence was suppressed when a 10-fold excess of 5-HT was present (<xref rid="f0005" ref-type="fig">Fig. 1</xref>A). The addition of different amounts of 5-HT to an agitating AS solution (<xref rid="f0005" ref-type="fig">Fig. 1</xref>B) showed that 5-HT was able to abolish the assembly of AS into mature amyloid fibrils in a concentration dependent way, even at sub-stoichiometric levels. Unless explicitly stated, the following experiments were all performed at a 10-fold 5-HT excess to ensure complete AS saturation.</p>
        <p>In parallel to ThioT fluorescence, the turbidity of the sample solutions was measured, which defines the formation of light scattering particles. The turbidity of the AS solution in the absence of 5-HT (<xref rid="f0010" ref-type="fig">Fig. 2</xref>A) increased already during the ThioT lag-phase (<xref rid="f0005" ref-type="fig">Fig. 1</xref>A). This is in accordance to previous studies <xref rid="bb0205 bb0210" ref-type="bibr">[41,42]</xref>, which describe the build-up of pre-amyloid, ThioT-negative aggregates preceding fibril assembly. A less prominent increase in turbidity was observed in the presence of 5-HT, suggesting the accumulation of non-amyloidogenic aggregates.</p>
        <p>We employed dynamic light scattering (DLS) for a more detailed analysis of the size composition of these aggregates. <xref rid="f0010" ref-type="fig">Fig. 2</xref>B shows the Stokes radii of the most prominent AS aggregates appearing in solution over time in the absence or in the presence of 5-HT. Monomeric AS had a Stokes radius of 2.6 nm, consistent with previous reports <xref rid="bb0215" ref-type="bibr">[43]</xref>. We also observed for AS alone that higher order species with mean radii up to 1 μm were generated over time, corresponding to the assembly of amyloid fibrils. The addition of 5-HT prevented the maturation of these amyloid fibrils in favor of aggregates with an initial mean size of up to 10 nm, which increased to approximatively 150 nm within 3–4 days (<xref rid="f0010" ref-type="fig">Fig. 2</xref>B). As shown by SDS–PAGE analysis, these aggregates were composed of differently sized SDS-resistant oligomers (<xref rid="f0010" ref-type="fig">Fig. 2</xref>C). Ultracentrifugation analysis indicated that the aggregates partitioned in the soluble fraction (<xref rid="ec0005" ref-type="supplementary-material">Fig. S1</xref>). Therefore, 5-HT does not suppress the assembly of AS completely but rather promotes the accumulation of soluble intermediate aggregates instead of mature amyloid fibrils, as suggested for other ligands <xref rid="bb0085 bb0095 bb0115 bb0220" ref-type="bibr">[17,19,23,44]</xref>.</p>
        <p><xref rid="f0010" ref-type="fig">Fig. 2</xref>C also shows a time-dependent shift of monomeric AS to a slightly higher sized band. We speculate that this might derive from a covalent reaction between AS and an oxidized derivative of 5-HT. In support to this, we noticed that this band shift was not observed under reducing conditions (<xref rid="f0010" ref-type="fig">Fig. 2</xref>D), suggesting that a covalent 5-HT:AS adduct might indeed form during the reaction. However, this adduct would not account for fibril suppression as 5-HT was still able to suppress amyloid growth in the presence of the reducing agent thiosulfate (<xref rid="f0010" ref-type="fig">Fig. 2</xref>E) <xref rid="bb0225" ref-type="bibr">[45]</xref>. Also, SDS-resistant dimer and tetramer bands appeared even under reducing conditions (<xref rid="f0010" ref-type="fig">Fig. 2</xref>D). These results both indicate that 5-HT was able to efficiently suppress fibril formation independently of an oxidative adduct accumulating during the reaction.</p>
        <p>To visualize the morphology of the observed aggregates, we recorded TEM images of samples collected at the end of the amyloid growth curve. In the absence of 5-HT, the sample was composed predominantly of entangled fibrils of varying length and approximate 5 nm width, along with a minor amount of smaller globular aggregates (<xref rid="f0015" ref-type="fig">Fig. 3</xref>A). In the presence of 5-HT, heterogeneously sized, small spherical (&lt; 50 nm) and large granular (100–200 nm) aggregates were the predominant species (<xref rid="f0015" ref-type="fig">Fig. 3</xref>B).</p>
        <p>In order to structurally characterize these aggregates, we used far-UV circular dichroism spectroscopy which proved very useful to distinguish the secondary structure conformation of differently folded AS species <xref rid="bb0230" ref-type="bibr">[46]</xref>. The spectrum of monomeric AS featured intrinsically unstructured patterns, i.e., a minimal signal readout, followed by a strong negative signal minimum below 210 nm (<xref rid="f0020" ref-type="fig">Fig. 4</xref>, dashed line). In contrast, the CD spectrum of mature AS amyloid fibrils was typical of β-sheets (<xref rid="f0020" ref-type="fig">Fig. 4</xref>, solid line), which corresponds to the conformation that AS adopts in amyloid fibers <xref rid="bb0035" ref-type="bibr">[7]</xref>. The signal showed a negative minimum around 220 nm and a positive ellipticity below 210 nm. For 5-HT generated AS aggregates, we observed a prominent CD-signal increase below 210 nm and a slight decrease of the CD-signal around 220 nm, compared to monomeric AS (<xref rid="f0020" ref-type="fig">Fig. 4</xref>, dash-dotted line). This corresponded to a decrease of the unstructured signal component in favor of the structured component, accounting for a reduced conformational flexibility of AS within these aggregates. As shown by secondary structure deconvolution of the respective CD spectra (<xref rid="t0005" ref-type="table">Table 1</xref>), structural disorder decreased from 91.9% for monomeric AS to 56.8% for intermediate aggregates. This was paralleled by a gradual increase of the beta-sheet component from 2.1% for monomeric AS to 34.9% for the intermediate aggregates and finally to 59.8% for the amyloid fiber sample. This indicates that the aggregates observed in the presence of 5-HT are partially structured and display a significant beta-sheet structural content.</p>
        <p>We noticed that, in aging aggregate preparations stored at RT containing AS and 5-HT, short amyloid fibrils were slowly formed after 6–8 weeks (<xref rid="ec0005" ref-type="supplementary-material">Fig. S2(A)</xref>). We thus assumed that the observed aggregates might represent kinetically stabilized “on-pathway” components of amyloid assembly. To discriminate between “on-pathway” and “dead-end,” we examined if they could act as nucleation seeds to promote AS amyloidogenesis. Nucleation consists of the early formation of transient, pre-fibrillar intermediates, which then convert into amyloids <xref rid="bb0030" ref-type="bibr">[6]</xref>. For this purpose, we induced fibril growth in the absence and in the presence of 5-HT-generated aggregates. <xref rid="f0005" ref-type="fig">Fig. 1</xref>A and <xref rid="ec0005" ref-type="supplementary-material">Fig. S2(B)</xref> show that amyloidogenesis was accelerated when these aggregates were used for seeding, identifying them as “on-pathway.”</p>
      </sec>
      <sec id="s0065">
        <label>3.2</label>
        <title>5-HT binds to intermediate aggregates</title>
        <p>We observed that sub-stoichiometric amounts of 5-HT were sufficient to affect AS amyloidogenesis (<xref rid="f0005" ref-type="fig">Fig. 1</xref>B and <xref rid="ec0005" ref-type="supplementary-material">Fig. S2</xref>(C)). Also, fibril growth was interrupted by the addition of 5-HT during the amyloid mid-growth phase (<xref rid="f0025" ref-type="fig">Fig. 5</xref>). This led us to suppose that, rather than binding to monomeric AS, this neurotransmitter binds to and stabilizes intermediate AS aggregates once they have formed.</p>
        <p>To prove our hypothesis, we used two-dimensional heteronuclear correlation NMR spectroscopy, which is suitable for measuring binding of a given ligand to a protein. The <sup><sup>1</sup></sup>H-<sup><sup>15</sup></sup>N HSQC spectrum of monomeric AS recorded at 25 °C showed limited signal dispersion typical for intrinsically unstructured proteins (<xref rid="ec0005" ref-type="supplementary-material">Fig. S3</xref>). For 5-HT binding to monomeric <sup><sup>15</sup></sup>N-AS, we expected significant shifts or intensity changes for some of the signals, as previously observed for other AS ligands <xref rid="bb0080 bb0085 bb0235 bb0240" ref-type="bibr">[16,17,47,48]</xref>. However, this did not occur upon the addition of 5-HT, as the spectra are virtually unchanged. This argues against binding of 5-HT to AS monomers.</p>
        <p>We expected that the <sup><sup>1</sup></sup>H-resonance signals of 5-HT should be sensitive to an interaction with AS aggregates. To show this, we recorded <sup><sup>1</sup></sup>H-NMR spectra of an agitating 5-HT:AS mixture and monitored signal variations over time. The signals of both 5-HT (<xref rid="f0030" ref-type="fig">Fig. 6</xref>, left) and AS (<xref rid="f0030" ref-type="fig">Fig. 6</xref>, right) displayed decreasing intensity within the first 4 days of agitation. The decrease in AS signal intensities was indicative of aggregate formation. As these are well beyond the NMR size limit, they yield extremely broad and undetectable signals. Their formation can thus be seen indirectly in the NMR spectra by the decrease of signal intensities. For 5-HT, a significant reduction of resonance intensities was observable only after 48 h, which can be explained by binding of 5-HT to accumulating aggregates rather than to monomers. A signal decrease was not observed for 5-HT in the absence of AS (<xref rid="ec0005" ref-type="supplementary-material">Fig. S4</xref>). Since there were no detectable chemical shift changes of 5-HT and we did not find a saturation transfer difference (STD) effect on 5-HT (see <xref rid="ec0005" ref-type="supplementary-material">supplementary data, Fig. S5</xref>), the binding of 5-HT to AS aggregates has to be relatively tight (K<sub>d</sub> &lt; mM). By finding the same results under reducing conditions, we could exclude that a covalent interaction between AS and an oxidized derivative of 5-HT might prevent STD (see <xref rid="ec0005" ref-type="supplementary-material">supplementary data, Fig. S5</xref>).</p>
        <p>An analogous result was observed by ultrafiltration analysis (<xref rid="f0035" ref-type="fig">Fig. 7</xref>). AS was agitated in the presence of 5-HT, and aliquots collected at different times of amyloidogenesis were centrifuged through an ultrafiltration device with a membrane cutoff of 3 kDa, which is permeable for unbound 5-HT but not for 5-HT bound to AS. As a consequence, binding of 5-HT to AS was expected to reduce the recovery of free 5-HT in the flow-through. The assay shows that monomeric AS (<italic>t</italic> = 30 min) was not able to retain 5-HT, which was recovered in the filtrate. In contrast, the recovery of 5-HT was significantly lower (74% less) for a sample collected at <italic>t</italic> = 100 h, indicating that a considerable amount of 5-HT remained bound to forming aggregates. These results show that 5-HT binds to AS aggregates rather than to monomeric AS.</p>
      </sec>
      <sec id="s0070">
        <label>3.3</label>
        <title>The interaction between 5-HT and AS is charge sensitive</title>
        <p>The above results indicate that the 5-HT binding regions might become exposed during amyloidogenesis. The acidic C-terminal region of AS becomes more accessible after the release of long-range contacts with the NAC core domain <xref rid="bb0245 bb0250" ref-type="bibr">[49,50]</xref> and ligands such as catechols, polyamines, and some cations target this region <xref rid="bb0240 bb0255 bb0260 bb0265" ref-type="bibr">[48,51–53]</xref>. To test if 5-HT binds to the C-terminal region, we tested an AS truncation mutant (ASΔ96) lacking the whole C-terminal region (aa 97–140). <xref rid="f0040" ref-type="fig">Fig. 8</xref>A shows the amyloid growth curve of ASΔ96, in the absence and in the presence of 5-HT. In direct contrast to what we observed for full-length AS (<xref rid="f0005" ref-type="fig">Fig. 1</xref>), 5-HT had a minimal effect on ASΔ96 amyloid growth (see also <xref rid="ec0005" ref-type="supplementary-material">Fig. S2(D) and Fig. S2(E)</xref>). This suggests that the C-terminal region of AS is required for the efficient suppression of 5-HT mediated amyloid growth.</p>
        <p>As the C-terminal region of AS has a negative net charge and 5-HT is cationic at physiological pH <xref rid="bb0270" ref-type="bibr">[54]</xref>, electrostatic forces might drive the interaction. This was indeed the case since 5-HT was no longer able to inhibit amyloidogenesis when the ionic strength of the solution was increased (300 mM NaCl) (<xref rid="f0040" ref-type="fig">Fig. 8</xref>B, <xref rid="ec0005" ref-type="supplementary-material">Fig. S2(F), Fig. S2(G)</xref>). A similar effect was observed after neutralizing the positive charge of the aliphatic 5-HT amino group by increasing the pH of the buffer above its pKa-value of 9.97 (<xref rid="f0040" ref-type="fig">Fig. 8</xref>C, <xref rid="ec0005" ref-type="supplementary-material">Fig. S2(H), Fig. S2(I)</xref>) <xref rid="bb0270" ref-type="bibr">[54]</xref>. 5-HT scaffold modifications provided further indications for charge effects. 5,7-hydroxytryptamine (5,7-HT), which differs from 5-HT by an additional hydroxy group at the aromatic ring (<xref rid="f0045" ref-type="fig">Fig. 9</xref>), was also able to suppress amyloid assembly (<xref rid="f0040" ref-type="fig">Fig. 8</xref>D and <xref rid="ec0005" ref-type="supplementary-material">Fig. S2(J)</xref>). In contrast, 5-hydroxyindoleacetic acid (5-HIAA), a 5-HT metabolite where the positively charged aliphatic amino group of 5-HT is replaced by a negatively charged carboxy group (<xref rid="f0045" ref-type="fig">Fig. 9</xref>), did not suppress amyloid growth (<xref rid="f0040" ref-type="fig">Fig. 8</xref>D and <xref rid="ec0005" ref-type="supplementary-material">Fig. S2(K)</xref>). In contrast, dopamine mediated inhibition of AS fibrillization is not significantly modulated by electrostatic forces since high salt conditions (500 mM NaCl) had no effect <xref rid="bb0130" ref-type="bibr">[26]</xref>. Collectively, these results demonstrate that charge perturbations critically affect the ability of 5-HT to efficiently interfere with AS amyloidogenesis.</p>
      </sec>
    </sec>
    <sec id="s0075">
      <label>4</label>
      <title>Discussion</title>
      <p>The intrinsic structural disorder of the PD key protein AS accounts for ligand binding promiscuity and conformational variance. Both issues are coupled to the generation of pathogenic AS aggregates. Yet, the exact circumstances dictating the formation of these species are unclear. We demonstrated that the neurotransmitter 5-HT profoundly influenced amyloidogenesis of AS, which was altered in favor of “on-pathway” intermediates.</p>
      <p>We show that 5-HT targets the C-terminal region of AS, as reported for dopamine and other functionally unrelated ligands <xref rid="bb0240 bb0255 bb0260 bb0265" ref-type="bibr">[48,51–53]</xref>. In contrast to them, 5-HT does not bind directly to monomeric AS molecules. Consequently, 5-HT does not influence initial steps of amyloidogenesis. Rather, 5-HT intervenes in the AS fibril assembly at a given intermediate growth stage, when partially folded soluble aggregates have already accumulated. This interrupts their further maturation. Reinke et al. <xref rid="bb0160" ref-type="bibr">[32]</xref> proposed a similar mechanism for a set of indolic derivatives which bind preferentially to pre-amyloid intermediates of the Alzheimer disease peptide Aβ. This suggests common interaction properties between indoles and different amyloid-forming proteins. The link between 5-HT and the non-motor symptoms of PD <xref rid="bb0165 bb0175" ref-type="bibr">[33,35]</xref> might account for a pathophysiological relationship between this particular neurotransmitter and AS in PD.</p>
      <p>Based on our results, we outline a model for the 5-HT-mediated AS aggregation (<xref rid="f0050" ref-type="fig">Fig. 10</xref>). The initial phase involves the 5-HT-independent interaction of AS monomers to form the early small intermediates (<xref rid="f0050" ref-type="fig">Fig. 10</xref>A). This might be initiated by the loosening of intramolecular constraints between the C-terminal region and the hydrophobic core region, as proposed by Dedmon et al. <xref rid="bb0245 bb0250" ref-type="bibr">[49,50]</xref>. The C-terminal region is not assembled within the β-sheet scaffold which is generated during fiber elongation but remains rather unstructured and solvent exposed (<xref rid="f0050" ref-type="fig">Fig. 10</xref>B) <xref rid="bb0275 bb0280" ref-type="bibr">[55,56]</xref>. We suggest that this facilitates the consequent interaction with 5-HT (gray spheres) (<xref rid="f0050" ref-type="fig">Fig. 10</xref>C), which takes place during the pre-fibrillar phase. Since the C-terminal region of AS is critical for the further maturation of pre-fibrils into amyloid fibers <xref rid="bb0275" ref-type="bibr">[55]</xref>, it is likely that binding of 5-HT to this region interferes with the assembly of mature fibrils (<xref rid="f0050" ref-type="fig">Fig. 10</xref>F). As a result, fibril generation is inhibited (<xref rid="f0050" ref-type="fig">Fig. 10</xref>E), resulting in the accumulation of the partially structured and kinetically stabilized intermediate aggregates (<xref rid="f0050" ref-type="fig">Fig. 10</xref>D).</p>
      <p>It remains to be established whether the 5-HT/AS interaction is either pathological or physiologically relevant in vivo. Despite the promotion of “on pathway” aggregation by 5-HT, the occurrence of SDS-resistant oligomeric intermediates (<xref rid="f0010" ref-type="fig">Fig. 2</xref>C) similar to those observed for dopamine induced “off-pathway” aggregation <xref rid="bb0085 bb0130" ref-type="bibr">[17,26]</xref> suggests some mechanistic overlap between these two processes. We speculate that an interaction between 5-HT and AS in serotonergic neurons might trigger neurotoxic effects paralleling those suggested for dopamine and AS in dopaminergic neurons. This is supported by the occurrence of AS-positive Lewy inclusions in serotonergic neurons <xref rid="bb0285" ref-type="bibr">[57]</xref>, which might imply molecular events similar to those eventually leading to dopaminergic cell death.</p>
      <p>The following are the supplementary materials related to this article.<supplementary-material content-type="local-data" id="ec0005"><caption><title>Supplementary data</title></caption><media xlink:href="mmc1.doc" mimetype="application" mime-subtype="msword"/></supplementary-material></p>
      <p>Supplementary materials related to this article can be found online at <ext-link ext-link-type="doi" xlink:href="10.1016/j.bbapap.2011.02.008">doi:10.1016/j.bbapap.2011.02.008</ext-link>.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bb0005">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lees</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Hardy</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Revesz</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Parkinson's disease</article-title>
          <source>Lancet</source>
          <volume>373</volume>
          <year>2009</year>
          <fpage>2055</fpage>
          <lpage>2066</lpage>
          <pub-id pub-id-type="pmid">19524782</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0010">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spillantini</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>V.M.</given-names>
            </name>
            <name>
              <surname>Trojanowski</surname>
              <given-names>J.Q.</given-names>
            </name>
            <name>
              <surname>Jakes</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Goedert</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Alpha-synuclein in Lewy bodies</article-title>
          <source>Nature</source>
          <volume>388</volume>
          <year>1997</year>
          <fpage>839</fpage>
          <lpage>840</lpage>
          <pub-id pub-id-type="pmid">9278044</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0015">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spillantini</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Crowther</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Jakes</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Goedert</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>95</volume>
          <year>1998</year>
          <fpage>6469</fpage>
          <lpage>6473</lpage>
          <pub-id pub-id-type="pmid">9600990</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0020">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Windisch</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hutter-Paier</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Wronski</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>The role of alpha-synuclein in neurodegenerative diseases: a potential target for new treatment strategies?</article-title>
          <source>Neurodegener. Dis.</source>
          <volume>5</volume>
          <year>2008</year>
          <fpage>218</fpage>
          <lpage>221</lpage>
          <pub-id pub-id-type="pmid">18322395</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0025">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weinreb</surname>
              <given-names>P.H.</given-names>
            </name>
            <name>
              <surname>Zhen</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Poon</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Conway</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Lansbury</surname>
              <given-names>P.T.</given-names>
            </name>
          </person-group>
          <article-title>NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded</article-title>
          <source>Biochemistry</source>
          <volume>35</volume>
          <year>1996</year>
          <fpage>13709</fpage>
          <lpage>13715</lpage>
          <pub-id pub-id-type="pmid">8901511</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0030">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uversky</surname>
              <given-names>V.N.</given-names>
            </name>
          </person-group>
          <article-title>Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation</article-title>
          <source>J. Neurochem.</source>
          <volume>103</volume>
          <year>2007</year>
          <fpage>17</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="pmid">17623039</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0035">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vilar</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Chou</surname>
              <given-names>H.T.</given-names>
            </name>
            <name>
              <surname>Lührs</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Maji</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Riek-Loher</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Verel</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Manning</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Stahlberg</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Riek</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>The fold of alpha-synuclein fibrils</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>105</volume>
          <year>2008</year>
          <fpage>8637</fpage>
          <lpage>8642</lpage>
          <pub-id pub-id-type="pmid">18550842</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0040">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kayed</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Head</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>McIntire</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Milton</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Cotman</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>Glabe</surname>
              <given-names>C.G.</given-names>
            </name>
          </person-group>
          <article-title>Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis</article-title>
          <source>Science</source>
          <volume>300</volume>
          <year>2003</year>
          <fpage>486</fpage>
          <lpage>489</lpage>
          <pub-id pub-id-type="pmid">12702875</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0045">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lashuel</surname>
              <given-names>H.A.</given-names>
            </name>
            <name>
              <surname>Hartley</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Petre</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Walz</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Lansbury</surname>
              <given-names>P.T.</given-names>
              <suffix>Jr.</suffix>
            </name>
          </person-group>
          <article-title>Neurodegenerative disease: amyloid pores from pathogenic mutations</article-title>
          <source>Nature</source>
          <volume>418</volume>
          <year>2002</year>
          <fpage>291</fpage>
          <pub-id pub-id-type="pmid">12124613</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0050">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Outeiro</surname>
              <given-names>T.F.</given-names>
            </name>
            <name>
              <surname>Putcha</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Tetzlaff</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Spoelgen</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Koker</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Hyman</surname>
              <given-names>B.T.</given-names>
            </name>
            <name>
              <surname>McLean</surname>
              <given-names>P.J.</given-names>
            </name>
          </person-group>
          <article-title>Formation of toxic oligomeric alpha-synuclein species in living cells</article-title>
          <source>PLoS ONE</source>
          <volume>4</volume>
          <year>2008</year>
          <fpage>e1867</fpage>
          <pub-id pub-id-type="pmid">18382657</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0055">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsika</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Moysidou</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Cushman</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gannon</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Sandaltzopoulos</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Giasson</surname>
              <given-names>B.I.</given-names>
            </name>
            <name>
              <surname>Krainc</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ischiropoulos</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Mazzulli</surname>
              <given-names>J.R.</given-names>
            </name>
          </person-group>
          <article-title>Distinct region-specific alpha-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration</article-title>
          <source>J. Neurosci.</source>
          <volume>30</volume>
          <year>2010</year>
          <fpage>3409-3344</fpage>
          <pub-id pub-id-type="pmid">20203200</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0060">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Danzer</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Haasen</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Karow</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Moussaud</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Habeck</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Giese</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kretzschmar</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hengerer</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Kostka</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Different species of alpha-synuclein oligomers induce calcium influx and seeding</article-title>
          <source>J. Neurosci.</source>
          <volume>27</volume>
          <year>2007</year>
          <fpage>9220</fpage>
          <lpage>9232</lpage>
          <pub-id pub-id-type="pmid">17715357</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0065">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wright</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>D.R.</given-names>
            </name>
          </person-group>
          <article-title>Unique copper-induced oligomers mediate alpha-synuclein toxicity</article-title>
          <source>FASEB J.</source>
          <volume>23</volume>
          <year>2009</year>
          <fpage>2384</fpage>
          <lpage>2393</lpage>
          <pub-id pub-id-type="pmid">19325037</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0070">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>H.Y.</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Maier</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Siebenhaar</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fernandez</surname>
              <given-names>C.O.</given-names>
            </name>
            <name>
              <surname>Lashuel</surname>
              <given-names>H.A.</given-names>
            </name>
            <name>
              <surname>Benz</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zweckstetter</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Structural properties of pore-forming oligomers of alpha-synuclein</article-title>
          <source>J. Am. Chem. Soc.</source>
          <volume>131</volume>
          <year>2009</year>
          <fpage>17482</fpage>
          <lpage>17489</lpage>
          <pub-id pub-id-type="pmid">19888725</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0075">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karpinar</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Balija</surname>
              <given-names>M.B.</given-names>
            </name>
            <name>
              <surname>Kügler</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Opazo</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Rezaei-Ghaleh</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Wender</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>H.Y.</given-names>
            </name>
            <name>
              <surname>Taschenberger</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Falkenburger</surname>
              <given-names>B.H.</given-names>
            </name>
            <name>
              <surname>Heise</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Riedel</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Fichtner</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Voigt</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Braus</surname>
              <given-names>G.H.</given-names>
            </name>
            <name>
              <surname>Giller</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Herzig</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Baldus</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jäckle</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Eimer</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Griesinger</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Zweckstetter</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models</article-title>
          <source>EMBO J.</source>
          <volume>28</volume>
          <year>2009</year>
          <fpage>3256</fpage>
          <lpage>3268</lpage>
          <pub-id pub-id-type="pmid">19745811</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0080">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lamberto</surname>
              <given-names>G.R.</given-names>
            </name>
            <name>
              <surname>Binolfi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Orcellet</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Bertoncini</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>Zweckstetter</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Griesinger</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Fernández</surname>
              <given-names>C.O.</given-names>
            </name>
          </person-group>
          <article-title>Structural and mechanistic basis behind the inhibitory interaction of PcTS on alpha-synuclein amyloid fibril formation</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <volume>106</volume>
          <year>2009</year>
          <fpage>21057</fpage>
          <lpage>21062</lpage>
          <pub-id pub-id-type="pmid">19948969</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0085">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ehrnhoefer</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Bieschke</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Boeddrich</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Herbst</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Masino</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Lurz</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Engemann</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Pastore</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wanker</surname>
              <given-names>E.E.</given-names>
            </name>
          </person-group>
          <article-title>EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <volume>15</volume>
          <year>2008</year>
          <fpage>558</fpage>
          <lpage>566</lpage>
          <pub-id pub-id-type="pmid">18511942</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0090">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leong</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Cappai</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Barnham</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Pham</surname>
              <given-names>C.L.</given-names>
            </name>
          </person-group>
          <article-title>Modulation of alpha-synuclein aggregation by dopamine: a review</article-title>
          <source>Neurochem. Res.</source>
          <volume>34</volume>
          <year>2009</year>
          <fpage>1838</fpage>
          <lpage>1846</lpage>
          <pub-id pub-id-type="pmid">19444607</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0095">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cappai</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Leck</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Tew</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Williamson</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Galatis</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Sharples</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Curtain</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>F.E.</given-names>
            </name>
            <name>
              <surname>Cherny</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Culvenor</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Bottomley</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>Masters</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Barnham</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>A.F.</given-names>
            </name>
          </person-group>
          <article-title>Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway</article-title>
          <source>FASEB J.</source>
          <volume>19</volume>
          <year>2005</year>
          <fpage>1377</fpage>
          <lpage>1379</lpage>
          <pub-id pub-id-type="pmid">15946991</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0100">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conway</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Rochet</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Bieganski</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Lansbury</surname>
              <given-names>P.T.</given-names>
            </name>
          </person-group>
          <article-title>Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct</article-title>
          <source>Science</source>
          <volume>294</volume>
          <year>2001</year>
          <fpage>1346</fpage>
          <lpage>1349</lpage>
          <pub-id pub-id-type="pmid">11701929</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0105">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Periquet</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fulga</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Myllykangas</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Schlossmacher</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Feany</surname>
              <given-names>M.B.</given-names>
            </name>
          </person-group>
          <article-title>Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo</article-title>
          <source>J. Neurosci.</source>
          <volume>27</volume>
          <year>2007</year>
          <fpage>3338</fpage>
          <lpage>3346</lpage>
          <pub-id pub-id-type="pmid">17376994</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0110">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Outeiro</surname>
              <given-names>T.F.</given-names>
            </name>
            <name>
              <surname>Klucken</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bercury</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Tetzlaff</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Putcha</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Quintas</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>McLean</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Hyman</surname>
              <given-names>B.T.</given-names>
            </name>
          </person-group>
          <article-title>Dopamine-induced conformational changes in alpha-synuclein</article-title>
          <source>PLoS ONE</source>
          <volume>4</volume>
          <year>2009</year>
          <fpage>e6906</fpage>
          <pub-id pub-id-type="pmid">19730729</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0115">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Norris</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Giasson</surname>
              <given-names>B.I.</given-names>
            </name>
            <name>
              <surname>Hodara</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Trojanowski</surname>
              <given-names>J.Q.</given-names>
            </name>
            <name>
              <surname>Ischiropoulos</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>V.M.</given-names>
            </name>
          </person-group>
          <article-title>Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations</article-title>
          <source>J. Biol. Chem.</source>
          <volume>280</volume>
          <year>2005</year>
          <fpage>21212</fpage>
          <lpage>21219</lpage>
          <pub-id pub-id-type="pmid">15817478</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0120">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mazzulli</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Mishizen</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Giasson</surname>
              <given-names>B.I.</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Nakashima</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Nagatsu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ota</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ischiropoulos</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates</article-title>
          <source>J. Neurosci.</source>
          <volume>26</volume>
          <year>2006</year>
          <fpage>10068</fpage>
          <lpage>10078</lpage>
          <pub-id pub-id-type="pmid">17005870</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0125">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alves da Costa</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Dunys</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Brau</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Wilk</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cappai</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Checler</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein antiapoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation</article-title>
          <source>J. Biol. Chem.</source>
          <volume>281</volume>
          <year>2006</year>
          <fpage>9824</fpage>
          <lpage>9831</lpage>
          <pub-id pub-id-type="pmid">16464850</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0130">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pham</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Leong</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>F.E.</given-names>
            </name>
            <name>
              <surname>Kenche</surname>
              <given-names>V.B.</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>A.F.</given-names>
            </name>
            <name>
              <surname>Gras</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Barnham</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Cappai</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner</article-title>
          <source>J. Mol. Biol.</source>
          <volume>387</volume>
          <year>2009</year>
          <fpage>771</fpage>
          <lpage>785</lpage>
          <pub-id pub-id-type="pmid">19361420</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0135">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bisaglia</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mammi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bubacco</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein</article-title>
          <source>J. Biol. Chem.</source>
          <volume>282</volume>
          <year>2007</year>
          <fpage>15597</fpage>
          <lpage>15605</lpage>
          <pub-id pub-id-type="pmid">17395592</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0140">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Latawiec</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Herrera</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Bek</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Losasso</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Candotti</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Benetti</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Carlino</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Kranjc</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lazzarino</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gustincich</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Carloni</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Legname</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Modulation of alpha-synuclein aggregation by dopamine analogs</article-title>
          <source>PLoS ONE</source>
          <volume>5</volume>
          <year>2010</year>
          <fpage>e9234</fpage>
          <pub-id pub-id-type="pmid">20169066</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0145">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Inbar</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bautista</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Takayama</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Assay to screen for molecules that associate with Alzheimer's related beta-amyloid fibrils</article-title>
          <source>Anal. Chem.</source>
          <volume>80</volume>
          <year>2008</year>
          <fpage>3502</fpage>
          <lpage>3506</lpage>
          <pub-id pub-id-type="pmid">18380488</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0150">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morshedi</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Rezaei-Ghaleh</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Ebrahim-Habibi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ahmadian</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nemat-Gorgani</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of amyloid fibrillation of lysozyme by indole derivatives—possible mechanism of action</article-title>
          <source>FEBS J.</source>
          <volume>274</volume>
          <year>2007</year>
          <fpage>6415</fpage>
          <lpage>6425</lpage>
          <pub-id pub-id-type="pmid">18028426</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0155">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohen</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Frydman-Marom</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rechter</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gazit</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives</article-title>
          <source>Biochemistry</source>
          <volume>45</volume>
          <year>2006</year>
          <fpage>4727</fpage>
          <lpage>4735</lpage>
          <pub-id pub-id-type="pmid">16605241</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0160">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reinke</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>She</surname>
              <given-names>H.Y.</given-names>
            </name>
            <name>
              <surname>Gestwicki</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <volume>19</volume>
          <year>2009</year>
          <fpage>4952</fpage>
          <lpage>4957</lpage>
          <pub-id pub-id-type="pmid">19640715</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0165">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fox</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Chuang</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Brotchie</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Serotonin and Parkinson's disease: on movement, mood, and madness</article-title>
          <source>Mov. Disord.</source>
          <volume>24</volume>
          <year>2009</year>
          <fpage>1255</fpage>
          <lpage>1266</lpage>
          <pub-id pub-id-type="pmid">19412960</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0170">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaudhuri</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Schapira</surname>
              <given-names>A.H.</given-names>
            </name>
          </person-group>
          <article-title>Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment</article-title>
          <source>Lancet Neurol.</source>
          <volume>8</volume>
          <year>2009</year>
          <fpage>464</fpage>
          <lpage>474</lpage>
          <pub-id pub-id-type="pmid">19375664</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0175">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>T.N.</given-names>
            </name>
            <name>
              <surname>Caudle</surname>
              <given-names>W.M.</given-names>
            </name>
            <name>
              <surname>Shepherd</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Noorian</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Iuvone</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Weinshenker</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Greene</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>G.W.</given-names>
            </name>
          </person-group>
          <article-title>Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity</article-title>
          <source>J. Neurosci.</source>
          <volume>29</volume>
          <year>2009</year>
          <fpage>8103</fpage>
          <lpage>8113</lpage>
          <pub-id pub-id-type="pmid">19553450</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0180">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kasten</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kertelge</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Brüggemann</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>van der Vegt</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Tadic</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Buhmann</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Steinlechner</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Behrens</surname>
              <given-names>M.I.</given-names>
            </name>
            <name>
              <surname>Ramirez</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Binkofski</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Siebner</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Raspe</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hagenah</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lencer</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Nonmotor symptoms in genetic Parkinson disease</article-title>
          <source>Arch. Neurol.</source>
          <volume>67</volume>
          <year>2010</year>
          <fpage>670</fpage>
          <lpage>676</lpage>
          <pub-id pub-id-type="pmid">20558386</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0185">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whitmore</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>B.A.</given-names>
            </name>
          </person-group>
          <article-title>Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases</article-title>
          <source>Biopolymers</source>
          <volume>89</volume>
          <year>2008</year>
          <fpage>392</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="pmid">17896349</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0190">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sreerama</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Venyaminov</surname>
              <given-names>S.Y.</given-names>
            </name>
            <name>
              <surname>Woody</surname>
              <given-names>R.W.</given-names>
            </name>
          </person-group>
          <article-title>Estimation of the number of helical and strand segments in proteins using CD spectroscopy</article-title>
          <source>Protein Sci.</source>
          <volume>8</volume>
          <year>1999</year>
          <fpage>370</fpage>
          <lpage>380</lpage>
          <pub-id pub-id-type="pmid">10048330</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0195">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delaglio</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Grzesiek</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vuister</surname>
              <given-names>G.W.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Pfeifer</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bax</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>NMRPipe: a multidimensional spectral processing system based on UNIX pipes</article-title>
          <source>J. Biomol. NMR</source>
          <volume>6</volume>
          <year>1995</year>
          <fpage>277</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="pmid">8520220</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0200">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>LeVine</surname>
              <given-names>H.</given-names>
              <suffix>III</suffix>
            </name>
          </person-group>
          <article-title>Quantification of beta-sheet amyloid fibril structures with thioflavin T</article-title>
          <source>Meth. Enzymol.</source>
          <volume>309</volume>
          <year>1999</year>
          <fpage>274</fpage>
          <lpage>284</lpage>
          <pub-id pub-id-type="pmid">10507030</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0205">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamin</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Uversky</surname>
              <given-names>V.N.</given-names>
            </name>
            <name>
              <surname>Fink</surname>
              <given-names>A.L.</given-names>
            </name>
          </person-group>
          <article-title>Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers</article-title>
          <source>FEBS Lett.</source>
          <volume>542</volume>
          <year>2003</year>
          <fpage>147</fpage>
          <lpage>152</lpage>
          <pub-id pub-id-type="pmid">12729915</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0210">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Uversky</surname>
              <given-names>V.N.</given-names>
            </name>
            <name>
              <surname>Fink</surname>
              <given-names>A.L.</given-names>
            </name>
          </person-group>
          <article-title>Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T</article-title>
          <source>Neurotoxicology</source>
          <volume>23</volume>
          <year>2002</year>
          <fpage>553</fpage>
          <lpage>567</lpage>
          <pub-id pub-id-type="pmid">12428728</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0215">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Falsone</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Kungl</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Rek</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Cappai</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Zangger</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>The molecular chaperone Hsp90 modulates intermediate steps of amyloid assembly of the Parkinson-related protein alpha-synuclein</article-title>
          <source>J. Biol. Chem.</source>
          <volume>284</volume>
          <year>2009</year>
          <fpage>31190</fpage>
          <lpage>31199</lpage>
          <pub-id pub-id-type="pmid">19759002</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0220">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meng</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Munishkina</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Fink</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Uversky</surname>
              <given-names>V.N.</given-names>
            </name>
          </person-group>
          <article-title>Molecular mechanisms underlying the flavonoid-induced inhibition of alpha-synuclein fibrillation</article-title>
          <source>Biochemistry</source>
          <volume>48</volume>
          <year>2009</year>
          <fpage>8206</fpage>
          <lpage>8212</lpage>
          <pub-id pub-id-type="pmid">19634918</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0225">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Gallagher</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Long</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Fink</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Uversky</surname>
              <given-names>V.N.</given-names>
            </name>
          </person-group>
          <article-title>At low concentrations, 3,4-dihydroxyphenylacetic acid (DOPAC) binds non-covalently to alpha-synuclein and prevents its fibrillation</article-title>
          <source>J. Mol. Biol.</source>
          <volume>388</volume>
          <year>2009</year>
          <fpage>597</fpage>
          <lpage>610</lpage>
          <pub-id pub-id-type="pmid">19328209</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0230">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uversky</surname>
              <given-names>V.N.</given-names>
            </name>
            <name>
              <surname>Fink</surname>
              <given-names>A.L.</given-names>
            </name>
          </person-group>
          <article-title>Conformational constraints for amyloid fibrillation: the importance of being unfolded</article-title>
          <source>Biochim. Biophys. Acta</source>
          <volume>1698</volume>
          <year>2004</year>
          <fpage>131</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="pmid">15134647</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0235">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bodner</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Maltsev</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Dobson</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Bax</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy</article-title>
          <source>Biochemistry</source>
          <volume>49</volume>
          <year>2010</year>
          <fpage>862</fpage>
          <lpage>871</lpage>
          <pub-id pub-id-type="pmid">20041693</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0240">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fernández</surname>
              <given-names>C.O.</given-names>
            </name>
            <name>
              <surname>Hoyer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Zweckstetter</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jares-Erijman</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Subramaniam</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Griesinger</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Jovin</surname>
              <given-names>T.M.</given-names>
            </name>
          </person-group>
          <article-title>NMR of alpha-synuclein–polyamine complexes elucidates the mechanism and kinetics of induced aggregation</article-title>
          <source>EMBO J.</source>
          <volume>23</volume>
          <year>2004</year>
          <fpage>2039</fpage>
          <lpage>2046</lpage>
          <pub-id pub-id-type="pmid">15103328</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0245">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dedmon</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Lindorff-Larsen</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Christodoulou</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Vendruscolo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Dobson</surname>
              <given-names>C.M.</given-names>
            </name>
          </person-group>
          <article-title>Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations</article-title>
          <source>J. Am. Chem. Soc.</source>
          <volume>127</volume>
          <year>2005</year>
          <fpage>476</fpage>
          <lpage>477</lpage>
          <pub-id pub-id-type="pmid">15643843</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0250">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bertoncini</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>Y.S.</given-names>
            </name>
            <name>
              <surname>Fernandez</surname>
              <given-names>C.O.</given-names>
            </name>
            <name>
              <surname>Hoyer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Griesinger</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Jovin</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Zweckstetter</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>102</volume>
          <year>2005</year>
          <fpage>1430</fpage>
          <lpage>1435</lpage>
          <pub-id pub-id-type="pmid">15671169</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0255">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>E.N.</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Paik</surname>
              <given-names>S.R.</given-names>
            </name>
          </person-group>
          <article-title>Dequalinium-induced protofibril formation of alpha-synuclein</article-title>
          <source>J. Biol. Chem.</source>
          <volume>281</volume>
          <year>2006</year>
          <fpage>3463</fpage>
          <lpage>3472</lpage>
          <pub-id pub-id-type="pmid">16330551</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0260">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lowe</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Pountney</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>P.H.</given-names>
            </name>
            <name>
              <surname>Gai</surname>
              <given-names>W.P.</given-names>
            </name>
            <name>
              <surname>Voelcker</surname>
              <given-names>N.H.</given-names>
            </name>
          </person-group>
          <article-title>Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain</article-title>
          <source>Protein Sci.</source>
          <volume>13</volume>
          <year>2004</year>
          <fpage>3245</fpage>
          <lpage>3252</lpage>
          <pub-id pub-id-type="pmid">15537754</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0265">
        <label>53</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mazzulli</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Armakola</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Dumoulin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Parastatidis</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Ischiropoulos</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Cellular oligomerization of alpha-synuclein is determined by the interaction of oxidized catechols with a C-terminal sequence</article-title>
          <source>J. Biol. Chem.</source>
          <volume>282</volume>
          <year>2007</year>
          <fpage>31621</fpage>
          <lpage>31630</lpage>
          <pub-id pub-id-type="pmid">17785456</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0270">
        <label>54</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pratuangdejkul</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Nosoongnoen</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Guerin</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Loric</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Conti</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Launay</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Manivet</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Conformational dependence of serotonin theoretical pK(a) prediction</article-title>
          <source>Chem. Phys. Lett.</source>
          <volume>420</volume>
          <year>2006</year>
          <fpage>538</fpage>
          <lpage>544</lpage>
        </element-citation>
      </ref>
      <ref id="bb0275">
        <label>55</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qin</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Fink</surname>
              <given-names>A.L.</given-names>
            </name>
          </person-group>
          <article-title>Role of different regions of alpha-synuclein in the assembly of fibrils</article-title>
          <source>Biochemistry</source>
          <volume>46</volume>
          <year>2007</year>
          <fpage>13322</fpage>
          <lpage>13330</lpage>
          <pub-id pub-id-type="pmid">17963364</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0280">
        <label>56</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Margittai</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Langen</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Investigation of alpha-synuclein fibril structure by site-directed spin labeling</article-title>
          <source>J. Biol. Chem.</source>
          <volume>282</volume>
          <year>2007</year>
          <fpage>24970</fpage>
          <lpage>24979</lpage>
          <pub-id pub-id-type="pmid">17573347</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0285">
        <label>57</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Braak</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ghebremedhin</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Rüb</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Bratzke</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Del Tredici</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Stages in the development of Parkinson's disease-related pathology</article-title>
          <source>Cell Tissue Res.</source>
          <volume>318</volume>
          <year>2004</year>
          <fpage>121</fpage>
          <lpage>134</lpage>
          <pub-id pub-id-type="pmid">15338272</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ack>
      <title>Acknowledgments</title>
      <p>This work was supported by the Austrian Science Fund (project no. P22400 to SFF and P20020 to KZ). RC is an NHMRC Senior Research Fellow. DICHROWEB is supported by grants to the BBSRC Centre for Protein and Membrane Structure and Dynamics (CPMSD).</p>
    </ack>
  </back>
  <floats-group>
    <fig id="f0005">
      <label>Fig. 1</label>
      <caption>
        <p>(A) ThioT amyloid growth kinetics of 100 μM AS in the absence (■) and in the presence of 1 mM 5-HT (○); 100 μM AS seeded with approximately 100 nM of 5-HT induced aggregates (□). (B) ThioT fluorescence of 100 μM AS after 5 days in dependence of increasing concentrations of 5-HT.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="f0010">
      <label>Fig. 2</label>
      <caption>
        <p>(A) Turbidity of 100 μM AS in the absence (■) and presence of 1 mM 5-HT (○). (B) DLS of 100 μM AS in the absence (■) and presence of 1 mM 5-HT (○). The mean Stokes radii of the predominating AS species of each sample were plotted against the time. (C) Denaturing SDS–PAGE aggregation profile of 100 μM AS agitating at 37 °C shows that SDS-resistant species appear over time in the presence of 1 mM 5-HT. (D) Denaturing SDS–PAGE aggregation profile of 100 μM AS agitating at 37 °C in the presence of 10 mM sodium thiosulfate. (E) The amyloid inhibiting effect of 5-HT measured at <italic>t</italic> = 100 h in the absence and in the presence of 10 mM of the reducing agent sodium thiosulfate.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="f0015">
      <label>Fig. 3</label>
      <caption>
        <p>TEM images of 100 μM AS in the absence (A) and in the presence (B) of 1 mM 5-HT. Samples were collected after 7 days agitation at 37 °C, 1200 rpm. Scale bars correspond to 200 nm.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="f0020">
      <label>Fig. 4</label>
      <caption>
        <p>CD spectra of 10 μM unagitated AS (dashed line); AS fibrils (solid line) and AS:5-HT = 1:10 (dash-dotted line; corrected with respect to the residual monomeric component) after 100 h agitation at 37 °C, 1200 rpm.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="f0025">
      <label>Fig. 5</label>
      <caption>
        <p>(A) ThioT amyloid growth kinetics of 100 μM AS (■), AS:5-HT = 1:10, with 5-HT added at mid-amyloid growth (arrow) (○). (B) TEM images of 100 μM AS at mid-amyloid growth in the absence of 5-HT and (C) after 100 h in the presence of 1 mM 5-HT added at mid-amyloid growth. Scale bars correspond to 200 nm.</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <fig id="f0030">
      <label>Fig. 6</label>
      <caption>
        <p>Overlay of one-dimensional <sup><sup>1</sup></sup>H spectra of 10 μM 5-HT agitated with 100 μM AS at 37 °C. The well separated signal of the 1-CH<sub>2</sub> group of the 2-aminoethyl chain of 5-HT (left) and an aromatic side chain signal of AS (right) were taken as representative signals.</p>
      </caption>
      <graphic xlink:href="gr6"/>
    </fig>
    <fig id="f0035">
      <label>Fig. 7</label>
      <caption>
        <p>Fluorescence emission spectra of 5-HT recovered in the flow through after ultrafiltration through a 3 kDa cutoff membrane: 5-HT in the absence of AS after 0 h (black solid line) and after 100 h agitation at 37 °C, 1200 rpm (dark gray solid line). 5-HT in the presence of AS after agitation at 37 °C, 1200 rpm for 30 min (dashed line), 24 h (dotted line), 48 h (dash-dotted line), and 100 h (short dotted line).</p>
      </caption>
      <graphic xlink:href="gr7"/>
    </fig>
    <fig id="f0040">
      <label>Fig. 8</label>
      <caption>
        <p>ThioT amyloid growth kinetics of (A) 150 μM ASΔ96 in the absence (■) and in the presence of 1 mM 5-HT (□); (B) 100 μM AS in the absence (■) and in the presence of 1 mM 5-HT (□) with 300 mM NaCl; (C) 100 μM AS in the absence (■) and in the presence of 1 mM 5-HT (□) at pH 11.6; (D) 100 μM AS in the absence (■) and in the presence of 1 mM 5,7-HT (▼) or 1 mM 5-HIAA (○).</p>
      </caption>
      <graphic xlink:href="gr8"/>
    </fig>
    <fig id="f0045">
      <label>Fig. 9</label>
      <caption>
        <p>Molecular formulae of the three compounds used in this study.</p>
      </caption>
      <graphic xlink:href="gr9"/>
    </fig>
    <fig id="f0050">
      <label>Fig. 10</label>
      <caption>
        <p>An in vitro model for the 5-HT-modulated suppression of AS amyloidogenesis. In a first step, amyloid-promoting conformational rearrangements of AS occur (A). During the consequent build-up of intermediate aggregates (B), the C-terminal region of AS (dashed line) remains solvent exposed <xref rid="bb0275 bb0280" ref-type="bibr">[55,56]</xref>. 5-HT molecules (gray spheres) bind to the C-terminal region (C) and arrest the build-up of mature amyloid fibrils (F). Instead, intermediate, partially structured, toxic aggregates become stabilized (D). Their conversion into amyloid fibrils is kinetically disfavored (E).</p>
      </caption>
      <graphic xlink:href="gr10"/>
    </fig>
    <table-wrap id="t0005" position="float">
      <label>Table 1</label>
      <caption>
        <p>Secondary structure deconvolution analysis of the CD spectra as shown in <xref rid="f0020" ref-type="fig">Fig. 4</xref>.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th/>
            <th align="left">α-Helix</th>
            <th align="left">β-Sheet</th>
            <th align="left">Unstructured</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">Monomeric AS</td>
            <td align="char">6.8%</td>
            <td align="char">2.1%</td>
            <td align="char">91.9%</td>
          </tr>
          <tr>
            <td align="left">5-HT-induced aggregates</td>
            <td align="char">10.3%</td>
            <td align="char">32.2%</td>
            <td align="char">56.8%</td>
          </tr>
          <tr>
            <td align="left">Amyloid fibers</td>
            <td align="char">5.8%</td>
            <td align="char">59.8%</td>
            <td align="char">34.2%</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </floats-group>
</article>